AI-generated summary
The authors propose a mechanistic framework for transcranial photobiomodulation as a possible adjunctive treatment in Rett syndrome, based on a review of disease pathways such as mitochondrial dysfunction, oxidative stress, neuroinflammation, and impaired synaptic plasticity. They report that these pathways converge with known effects of the light therapy, but describe the idea as speculative. The authors recommend preclinical studies and early feasibility trials rather than drawing clinical conclusions.
- Who or what was studied
- Individuals with Rett syndrome (theoretical framework; no patients studied)
- Limits stated in the abstract
- The abstract describes the work as a mechanistic review and hypothesis, with no clinical data, and the authors state the proposal is speculative.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Photobiomodulation, Neuroinflammation, Oxidative stress, Neuromodulation, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.